首页 > 市场调查报告书 > 医疗设备

体外诊断生技设备

市场调查报告书

商品编码

1588575

全球酵素连结免疫吸附检测市场 - 2024-2031

Global Enzyme-Linked Immunosorbent Assay Market - 2024-2031

出版日期: 2024年11月08日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

2023年，全球酵素连结免疫吸附检测市场规模达21.4亿美元，预计2031年将达到33.5亿美元，2024-2031年预测期间复合年增长率为5.8%。

酵素连结免疫吸附测定可用于检测和估计荷尔蒙水平，如人类绒毛膜促性腺激素 (HCG)、卵泡刺激素 (FSH) 和睪固酮，以及追踪社区中的疾病爆发，如衣原体或流感（流感），并筛检捐血中可能的病毒成分，例如爱滋病毒。它可以检测非医疗药物的使用情况，例如体内是否有安非他明和可卡因。

由于酶联免疫吸附测定检测抗体的特异性和识别性，全球范围内不断增加的传染病预计将推动对酶联免疫吸附测定检测的需求。例如，根据世界卫生组织 (WHO) 2024 年全球肝炎报告，病毒性肝炎导致的死亡人数正在上升。该疾病是世界第二大传染病死亡原因，每年造成 130 万人死亡。

市场动态：

驱动程式和限制

传染病发生率增加

传染病发病率的上升预计将推动酶联免疫吸附测定市场的成长。随着传染病数量的不断增加，实验室对酵素连结免疫吸附测定测试的需求不断增加。使用 ELISA 可以检测和测量针对莱姆病、布鲁氏菌病、梅毒、HIV 和肝炎等多种传染病的抗体。

酵素连结免疫吸附测定是最广泛使用的诊断程序之一，用于识别与传染病相关的抗体、抗原和其他生物标记。随着传染病数量的不断增加，政府组织、诊断中心和其他实验室依靠酵素连结免疫吸附测定来检测抗体。全球范围内的传染病数量不断增加。

例如，2022 年，疾病预防控制中心从州卫生机构和哥伦比亚特区收到约 63,000 例莱姆病病例的报告。这一数字反映了常规国家监测期间记录的病例，这只是公共卫生专业人员追踪疾病的一种方法。根据最近使用替代方法的预测，美国每年将有大约 476,000 人被诊断出患有莱姆病并接受治疗。这个数字可能包括根据临床怀疑接受治疗但没有莱姆病的患者。

这些传染病以及其他疾病需要利用酵素连结免疫吸附测定试剂盒来检测抗体和生物标记。因此，传染病发病率的增加预计将推动酶联免疫吸附测定市场的成长。

替代技术的替代威胁

其他技术替代的机会是 ELISA（酶联免疫吸附测定）市场成长和采用的主要障碍。随着创新诊断和研究技术的出现，它们带来了诸如更高的灵敏度、更快的发现和更低的成本等优势，有可能取代或减少传统 ELISA 检测的必要性。因此，上述因素可能会阻碍酵素连结免疫吸附检测市场的发展

Enzyme-linked Immunosorbent Assay is useful for detecting and estimating hormone levels such as human chorionic gonadotropin (HCG), follicle-stimulating hormone (FSH), and testosterone, as well as tracking disease outbreaks in communities such as chlamydia or influenza (the flu), and screening blood donations for possible viral components such as HIV. It detects nonmedical drug usage, such as the presence of amphetamines and cocaine in the body.

Rising infectious diseases globally are expected to drive the demand for enzyme-linked immunosorbent assay tests due to their specificity and identification of the antibodies. For instance, according to the World Health Organization's (WHO) 2024 Global Hepatitis Report, the number of deaths from viral hepatitis is rising. The disease is the second leading infectious cause of death in the world, accounting for 1.3 million deaths annually.

Market Dynamics: Drivers & Restraints

Increasing incidence of infectious diseases

The rising incidence of infectious diseases is expected to drive the enzyme-linked immunosorbent assay market growth. With the rising number of infectious diseases, there is a growing demand for enzyme-linked immunosorbent assay tests in laboratories. Antibodies against several infectious diseases such as Lyme disease, brucellosis, syphilis HIV and hepatitis among others can be detected and measured using ELISA.

Enzyme-linked immunosorbent assay is one of the most widely used diagnostic procedures for identifying antibodies, antigens, and other biomarkers linked to infectious illnesses. With the rising number of infectious diseases, government organizations, diagnostic centers and other laboratories depend on enzyme-linked immunosorbent assay for detecting the antibodies. There is a growing number of infectious diseases globally.

For instance, in 2022, the CDC received reports of about 63,000 cases of Lyme disease from state health agencies and the District of Columbia. This figure reflects cases recorded during routine national surveillance, which is simply one method used by public health professionals to track diseases. According to recent predictions utilizing alternative approaches, approximately 476,000 people in the United States will be identified and treated for Lyme disease each year. This number is likely to include patients treated based on clinical suspicion but do not have Lyme disease.

These infectious diseases, along with other diseases, require the utilization of enzyme-linked immunosorbent assay kits to detect antibodies and biomarkers. Thus, the increasing incidence of infectious diseases is expected to drive the Enzyme-Linked Immunosorbent Assay market growth.

Threat of substitution from alternative technologies

The chance of substitution from other technologies is a key obstacle to the growth and adoption of the ELISA (Enzyme-Linked Immunosorbent Assay) market. As innovative diagnostic and research technologies emerge, they provide benefits such as increased sensitivity, faster findings, and lower costs, potentially replacing or reducing the necessity for traditional ELISA assays. Thus, the above factors could hinder the enzyme-linked immunosorbent assay market

Segment Analysis

The global enzyme-linked immunosorbent assay market is segmented based on test type, product, application, end-user and region.

Sandwich ELISA segment is expected to dominate the enzyme-linked immunosorbent assay market share

The sandwich ELISA segment is expected to hold a major portion of the enzyme-linked immunosorbent assay market share. Sandwich ELISAs are the most common type of ELISA. The antigen is sandwiched between two specific antibodies, often known as matched antibody pairs. A microplate is covered with a capture antibody, a sample is added, and the protein of interest adheres to the plate and becomes immobilized.

A sandwich ELISA is more sensitive and robust because the antibody binds to two different sites on the antigen. This improves the binding selectivity of both the primary capture and detection antibodies to the antigen. The sandwich ELISA format is widely utilized due to its sensitivity and specificity.

New sandwich ELISA kits are being introduced into the market by several players which could contribute to the segment's expansion. An increasing number of product launches could help drive the segment's growth. For instance, in June 2024, ArcticZymes Technologies launched its SAN HQ 2.0 ELISA kit. This traditional sandwich ELISA is designed to detect and quantify the SAN HQ 2.0 enzyme in samples taken from the manufacturing stages of a complicated biomanufacturing process, such as the creation of viral vectors.

Thus, the sandwich ELISA segment is expected to hold the major portion of the enzyme-linked immunosorbent assay market share with the increasing innovation of new sandwich ELISA kits and their effectiveness in finding antibodies over other types of tests.

Geographical Analysis

North America is expected to hold a significant position in the enzyme-linked immunosorbent assay market share

North America is expected to hold a dominant position in the enzyme-linked immunosorbent assay market share owing to the increasing innovation of technological products, increasing research and development, the presence of a large number of key market players, and the rising incidence of infectious diseases. The region has highly equipped laboratories and it will invest more in the R&D department.

Several key players introduce a wide range of enzyme-linked immunosorbent assay products and kits with advanced features which could expand the region's market expansion. For instance, on February 13, 2023, Charles River Laboratories International, Inc. launched its first Enzyme-Linked Immunosorbent Assay (ELISA) Kit for the detection and quantitation of residual host cell proteins (HCP) in CHO-based biotherapeutics.

Similarly, on May 24, 2022, Molecular Devices, LLC. unveiled five ready-made workcells for enzyme-linked immunosorbent assay (ELISA) workflows, with automation capabilities ranging from entry-level to advanced. Automation of labor-intensive plate-based assays improves walkaway time, throughput, and reproducibility by lowering the number of common, repetitive, hands-on steps for researchers.

The introduction of advanced instruments and systems will increase the adoption of these enzyme-linked immunosorbent assay products by several laboratories, diagnostic centers and research institutes, which will increase the demand for the products and expand of region's market as well. Several market players in the region invest huge resources in innovating enzyme-linked immunosorbent assay products. Thus, the above factors are expected to drive the region's market growth.

Market Segmentation

By Test Type

Direct ELISA
Indirect ELISA
Sandwich ELISA
Competitive ELISA

By Product

Kits & Reagents
ELISA Analyzers
- Automated
- Semi-automated

By Application

Drug Discovery
Infectious Diseases
Cancer Detection
Protein Quantification
Others

By End-user

Hospitals
Academic and Research Institutes
Pharmaceutical & Biotechnology Companies
Diagnostic Laboratories
Others

By Region

North America
- The U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Middle East and Africa

Competitive Landscape

The major global players in the market include Thermo Fisher Scientific, Inc., American Laboratory Products Company (ALPCO), ZEUS Scientific, Inc., Life Technologies Corporation, Bio-Rad Laboratories, Inc., QuidelOrtho Corporation, Biomerieux S.A., Gemelli Biotech, BD

and Enzo Biochem Inc. among others.

Why Purchase the Report?

To visualize the global enzyme-linked immunosorbent assay market segmentation based on test type, product, application, end-user, and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of enzyme-linked immunosorbent assay market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as Excel consisting of key products of all the major players.

The global enzyme-linked immunosorbent assay market report would provide approximately 53 tables, 47 figures, and 176 pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Test Type
3.2. Snippet by Product
3.3. Snippet by Application
3.4. Snippet by End-user
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing incidence of infectious diseases
- 4.1.2. Restraints
  - 4.1.2.1. Threat of substitution from alternative technologies
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion

6. By Test Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 6.1.2. Market Attractiveness Index, By Test Type
6.2. Direct ELISA*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Indirect ELISA
6.4. Sandwich ELISA
6.5. Competitive ELISA

7. By Product

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 7.1.2. Market Attractiveness Index, By Product
7.2. Kits & Reagents*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. ELISA Analyzers
- 7.3.1. Automated
- 7.3.2. Semi-automated

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Drug Discovery*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Infectious Diseases
8.4. Cancer Detection
8.5. Protein Quantification
8.6. Others

9. By End-user

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
- 9.1.2. Market Attractiveness Index, By End-user
9.2. Hospitals*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Academic and Research Institutes
9.4. Pharmaceutical & Biotechnology Companies
9.5. Diagnostic Laboratories
9.6. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
  - 10.2.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
  - 10.2.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  - 10.2.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  - 10.2.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.3.1. The U.S.
  - 10.2.3.2. Canada
  - 10.2.3.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
  - 10.3.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
  - 10.3.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  - 10.3.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  - 10.3.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.3.1. Germany
  - 10.3.3.2. UK
  - 10.3.3.3. France
  - 10.3.3.4. Italy
  - 10.3.3.5. Spain
  - 10.3.3.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
  - 10.4.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
  - 10.4.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  - 10.4.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.4.1. Brazil
  - 10.4.4.2. Argentina
  - 10.4.4.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
  - 10.5.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
  - 10.5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  - 10.5.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.4.1. China
  - 10.5.4.2. India
  - 10.5.4.3. Japan
  - 10.5.4.4. South Korea
  - 10.5.4.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
  - 10.6.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
  - 10.6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  - 10.6.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Thermo Fisher Scientific, Inc.*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. American Laboratory Products Company (ALPCO)
12.3. ZEUS Scientific, Inc.
12.4. Life Technologies Corporation
12.5. Bio-Rad Laboratories, Inc.
12.6. QuidelOrtho Corporation
12.7. bioMerieux S.A.
12.8. Gemelli Biotech
12.9. BD
12.10. Enzo Biochem Inc.

LIST NOT EXHAUSTIVE